MARKETWIRE.NET

Decode Your Next Market Move

Global Industry Analysts, Inc. (GIA) launches comprehensive analysis of industry segments, market trends, growth drivers, market share, size and demand forecasts on the global 3D Cell Culture market. Market segmentation includes Product (Scaffold-based, Scaffold-free, Microfluidics-based, and Magnetic & Bioprinted).

Find Out More About Regions, Brands, Dominant, Active & Niche Companies Covered in the Report

24 November 3:44 a.m., Silicon Valley, California - According to the new market research report, the global market for 3D Cell Culture is projected to grow at a CAGR of 13.7% reach US$2.4 billion by 2027, driven by growing adoption of 3D cell culture techniques for application in a wide range of areas, including tissue engineering, stem cell biology, clinical applications, cancer research, and drug discovery. Rise in the number of people affected by diseases, such as cancer, and growing use by hospitals, academic and research laboratories, and pharmaceutical and biotech companies are the other factors driving growth. The market is witnessing increasing shift from standard 2D cell culture toward 3D cell culture as the latter offer a suitable model that can simulate in-vivo cell behaviors, morphology, physiology and organization. The use of scaffolds, representing micro-organized cell supports that aid cell differentiation and growth, facilitates users to assemble multi-layer 3D cells structures for studies. The global 3D cell culture market is gaining significantly from availability of required funding for various research projects.

Recent technological advancements have led to the launch of various advanced 3D cell culture tools and methods. Moreover, the market growth is being fuelled by increasing application of 3D cell culture in drug development and toxicology testing, increasing R&D spending by major market players, and growth in government and private investor funding initiatives for developing innovative tools to provide affordable and effective treatment for various critical diseases. In addition, rising research activities, benefits of 3D cell culture in replacing animals in research and pharmaceutical testing, and increasing demand for organ transplantation are further propelling the market growth. The superiority of 3D cell culture in offering greater stability as well as longer lifespan in comparison to 2D cell culture is another major factor driving the global market for 3D cell culture.

While stem cell research is anticipated to be a popular application, factors like growing focus on regenerative medicine, rising incidence of oncological diseases, and increasing adoption of 3D cell cultures in the pharmaceutical industry are expected to drive the market growth. The 3D cell culture market is poised to be positively influenced by rising demand for organ transplantation, while scaffold-free products are likely to register the fastest growth rate. The market is slated to also gain from increasing use of 3D cell cultures in research institutes and laboratories.

Research Methodology
This latest edition of the research study is conducted and published by Global Industry Analysts, Inc., in close collaboration with senior executives in the industry driving strategy, business development, marketing, sales, product management, technology and operations. The views, opinions and findings presented are based on validated engagements from a total executive pool size of 2193. Among this pool, 393 direct interactions with domain experts were carried out via our proprietary market research platform, MarketGlass. Among the 66 unique participations, a total of 31 validated responses were received as part of this report's primary research outreach program. We are unique in the industry to provide our clients with the validated list executive engagements and the complete project data stack.

Key Competitors Covered in the Report -
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
GE Healthcare
MilliporeSigma
Kuraray Co., Ltd.
Charles River Laboratories International, Inc.
F. Hoffmann-La Roche AG
JSR Corporation
QIAGEN GmbH
Himedia Laboratories

Segments Covered in the Report -
Product (Scaffold-based, Scaffold-free, Microfluidics-based, Magnetic & Bioprinted)
Application (Cancer & Stem Cell Research, Drug Discovery & Toxicology Testing, Tissue Engineering & Regenerative Medicine)

Geographies Analyzed in the Report -
World
USA
Canada
Japan
China
Europe
France
Germany
Italy
UK
Rest of Europe
Asia-Pacific
Rest of World.

View Executive Engagement Dashboards, COVID Impact Questionnaires & Get Complimentary Access to Methodology & Full-Text Secondary Sources

For enquiries e-mail us at sales@strategyR.com .

For cutting edge analyst reviews on top industries, follow us on Twitter and connect with us on LinkedIn

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) (www.strategyr.com) is the world`s only influencer driven AI powered market research company. Serving more than 41,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for 33 years, offering the widest coverage of topics, geographic markets, competitive brands, and companies profiled.

Contact Us:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
Email: sales@StrategyR.com